Abzena secures $5M ADC manufacturing contract with US biotech

Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and GMP manufacturing services for an antibody-drug conjugate (ADC) valued at over $5 million. Services will be carried out in Bristol, PA and San Diego, CA.

“The value of the entire process development and GMP manufacturing services exceeds $5 million, with the majority of the services to be provided within the next 12 months.”biospace.com

• 1 source
• biospace.comAbzena Secures Contract for Integrated ADC Manufacturing Services to U.S. Biotech Company - BioSpaceJef AkstDec 11, 2017

Summarized from public sources; check the original articles before acting on it.